The revised system gives states greater leeway than they’ve had to cut value-based purchasing deals with pharma companies on innovative but expensive drugs.

Various scenarios within medical diagnostics are among the AI use cases that an official European watchdog has flagged as a potential source of hazards to fundamental human rights.

The Pharmaceutical Research and Manufacturers of America (PhRMA) is combining forces with two other groups to challenge the FDA final rule allowing broad, state-by-state importation of drugs from Canada.

President-elect Joe Biden wants to drop Medicare’s eligibility age to 60. If he succeeds, the move might bring in well more than 20 million new enrollees. What are the odds he’ll plant that piece of a potentially sweeping healthcare agenda?  

A healthcare research firm specializing in purchasing has considered the post-election landscape from the vantage point of large employers offering health benefits to their workers.

As Joe Biden makes plans to intensify the federal response to the COVID crisis, he can expect support on that agenda item from 77% of Democrats, 62% of independents, 55% of Republicans and 50% of others.

The researchers say their AI technique produces an 11% boost in accuracy over that supplied by other contemporary flu forecasting systems.

Physicians who lived in three of the most populous states and were eligible to vote from 2006 to 2018 did so at a rate 14 percentage points lower than the population as a whole.